Intrinsic Value of S&P & Nasdaq Contact Us

Heartflow, Inc. Common Stock HTFL NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$38.00
+30%

Heartflow, Inc. Common Stock (HTFL) generated $-54.02M in operating cash flow for fiscal year 2025. After capital expenditures of $5.03M, free cash flow was $-59.05M.

Free cash flow margin was -33.5% of revenue. Cash conversion ratio was 0.46x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (70/100, Pass) — $-59.05M (-33.5% FCF margin) supports a durable competitive advantage
  • INCOME (10/100) — Cash conversion ratio was 0.46x suggests some earnings are non-cash items

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
52/100
SG Score
View full scorecard →
~
VALUE
58/100
Price-to-Earnings & upside
→ Valuation
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
70/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Heartflow, Inc. Common Stock Cash Flow History
Metric TTM FY2025 FY2024 FY2023
Operating Cash Flow $-54.02M$-54.02M$-69M$-76.43M
Capital Expenditure $-5.03M$-5.03M$-4.36M$-6.11M
Free Cash Flow $-59.05M$-59.05M$-73.36M$-82.54M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message